Measurement of extracellular vesicles and their role in cancer-associated thrombosis
Extracellular vesicles (EV) are submicron vesicles released from activated cells, apoptotic cells and cancer cells...
AUTHORS
Yohei Hisada
Postdoctoral Fellow, Division of Hematology/Oncology, Department of Medicine, Nigel Mackman Laboratory, University of North Carolina at Chapel Hill, USA
Yohei Hisada earned his Ph.D. in the University of Tokyo in 2014. During his graduate studies, he developed a new method for cancer therapy/diagnosis by targeting fibrin in cancer tissue using a monoclonal antibody produced in Dr. Yasuhiro Matsumura’s laboratory. In 2014, he joined Dr. Nigel Mackman’s laboratory in the University of North Carolina at Chapel Hill. Currently, as a postdoctoral fellow, he is studying the mechanisms of cancer-associated venous thrombosis using mouse models.
Yohei Hisada earned his Ph.D. in the University of Tokyo in 2014. During his graduate studies, he developed a new method for cancer therapy/diagnosis by targeting fibrin in cancer tissue using a monoclonal antibody produced in Dr. Yasuhiro Matsumura’s laboratory. In 2014, he joined Dr. Nigel Mackman’s laboratory in the University of North Carolina at Chapel Hill. Currently, as a postdoctoral fellow, he is studying the mechanisms of cancer-associated venous thrombosis using mouse models.
Mouse models of cancer-associated thrombosis
Cancer patients have 4-7 fold increased risk of venous thromboembolism (VTE) compared with a general population ....